Athersys, Inc completes first clinical trial

According to Cleveland.com, Athersys, Inc has successfully completed treating its first clinical trial patient at the Cleveland Clinic. They're using stem cell therapy to determine the maximum dosage of Multistem, a medicine that is used after a heart attack.

B.J. Lehmann, president and chief operating officer, at Athersys, had this to say about the success:

"We are excited about the potential of MultiStem to provide benefit in multiple diseases and conditions, and we look forward to providing additional information about this Phase I clinical trial and other studies as we move our programs ahead."